每年專案
個人檔案
學歷
- 2009-2013 臺北醫學大學臨床醫學研究所博士
- 2006-2008 國立臺灣大學臨床醫學研究所碩士
- 1993-2000 國立臺灣大學醫學系畢業
經歷
- 2021.08- 臺北醫學大學附設醫院外科部主任
- 衛生福利部雙和醫院外科部主任
- 2020.08- 臺北醫學大學醫學系外科學科一般外科主任
- 2018.02- 臺北醫學大學醫學系外科學科副教授
- 2013.10-2018.01 臺北醫學大學醫學系外科學科助理教授
- 2009.02-2013.09 臺北醫學大學醫學系外科學科講師
- 2005.07-2008.10 慈濟醫院台北分院一般外科主治醫師
- 2000.07-2005.06 臺大醫院外科部住院醫師
研究興趣
- 乳癌, 癌症轉移
指紋
- 1 類似的個人檔案
網路
研究成果
- 59 文章
-
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study
Tsai, J. H., Li, C. L., Yeh, D. C., Hung, C. S., Hung, C. C., Lin, C. Y. & Kuo, Y. L., 2023, (接受/付印) 於: Breast Cancer Research and Treatment. 199, 1, p. 47-55 9 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, 於: BioMed Research International. 2022, 1322788.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取2 引文 斯高帕斯(Scopus) -
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
Wei, P. L., Lin, J. C., Hung, C. S., Makondi, P. T., Batzorig, U., Chang, T. C., Huang, C. Y. & Chang, Y. J., 2022, 於: International Journal of Medical Sciences. 19, 1, p. 34-46 13 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer
Lin, R. K., Su, C. M., Lin, S. Y., Thi Anh Thu, L., Liew, P. L., Chen, J. Y., Tzeng, H. E., Liu, Y. R., Chang, T. H., Lee, C. Y. & Hung, C. S., 12月 2022, 於: Molecular Medicine. 28, 1, 67.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 引文 斯高帕斯(Scopus) -
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
Ansar, M., Thu, L. T. A., Hung, C. S., Su, C. M., Huang, M. H., Liao, L. M., Chung, Y. M. & Lin, R. K., 11月 7 2022, 於: Frontiers in Oncology. 12, 1004261.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Lin, S. (Creator), Ansar, M. (Creator), Hung, C. (Contributor), Lin, R. (Creator), Chang, S. (Contributor), Chen, J. (Creator), Jain, S. (Creator), Liew, P. (Contributor) & Wang, S. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.4974518.v1, https://doi.org/10.6084%2Fm9.figshare.c.4974518.v1
資料集: Dataset
-
Additional file 1 of Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
Wang, S. (Contributor), Chen, J. (Creator), Ansar, M. (Creator), Liew, P. (Contributor), Hung, C. (Contributor), Jain, S. (Creator), Chang, S. (Contributor), Lin, R. (Creator) & Lin, S. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12291872.v1, https://doi.org/10.6084%2Fm9.figshare.12291872.v1
資料集: Dataset